-
Mashup Score: 0Christopher Bunick, MD, PhD, Reviews Crucial Discussion of Biologics for AD and More - 11 month(s) ago
Bunick spoke at the Fall Clinical Dermatology Conference for PAs and NPs to discuss important considerations of biologics use for atopic dermatitis management.
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 1PRP And Biologics For Treatment Of UCL Tears - BSM 2022 - 12 month(s) ago
Watch this outstanding video presentation from the Baseball Sports Medicine 2022 Conference, as Head Team Physician of the Colorado Rockies, Dr. Thomas Noon…
Source: YouTubeCategories: Latest Headlines, OrthopedicsTweet-
#ThrowingThursday: PRP & Biologics For UCL Tears In this video Dr. Thomas Noonan, Head Team Physician of the Colorado @Rockies discusses the intricacies of #PRP & #biologics for treating elbow UCL injuries 💪 https://t.co/BzU7u67YN2 📽️ #understandingtommyjohn #sportsmedicine
-
-
Mashup Score: 0Biologic Therapies Summit - 12 month(s) ago
Highlights from the Cleveland Clinic Biologic Therapies Summit, including perspectives and interviews with leading researchers and clinicians, plus archives of past meetings.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet-
Biologic Therapies Summit X and Vasculitis 2023 is underway! Make sure to check out https://t.co/OFcLzeCqjX for all of Healio's coverage of the meeting #RheumTwitter #vasculitis #biologics https://t.co/W23ryJVYsr
-
-
Mashup Score: 1Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials - Respiratory Research - 12 month(s) ago
Background Individualized prediction of treatment response may improve the value proposition of advanced treatment options in severe asthma. This study aimed to investigate the combined capacity of patient characteristics in predicting treatment response to mepolizumab in patients with severe asthma. Methods Patient-level data were pooled from two multinational phase 3 trials of mepolizumab in…
Source: BioMed CentralCategories: Latest Headlines, PulmonologyTweet-
Can we predict who will benefit most from #biologics in severe #asthma? A post-hoc #analysis of two phase 3 trials https://t.co/W5XDHhACGQ https://t.co/OxFVjTZ78m
-
-
Mashup Score: 0Using Biologic Treatments in Atopic Dermatitis - 1 year(s) ago
Andrew Blauvelt, MD, MBA, discusses his RAD 2023 session, “Biologics for atopic dermatitis.”
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet-
As part of Sunday's mini symposium on systemic therapies, Andrew Blauvelt, MD, MBA, discussed #biologics for #AtopicDermatitis. https://t.co/mA5G9MksuZ
-
-
Mashup Score: 0Biologics May Prevent PsA in Patients With Psoriasis - 1 year(s) ago
Because biologics are used to treat both conditions, researchers hypothesized they may be helpful to prevent psoriatic arthritis (PsA).
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Researchers hypothesized #biologics may be helpful in preventing psoriatic arthritis (#PsA ). Read more! https://t.co/al3gALcQSI https://t.co/uHqD7OYvCh
-
-
Mashup Score: 0Patients With AD Have More Options With Biologics, JAK Inhibitors, Says Dr Emma Guttman-Yassky - 1 year(s) ago
With both biologics and Janus kinase (JAK) inhibitors available to treat atopic dermatitis, providers have more options for patients, said Emma Guttman-Yassky, MD, PhD, FAAD, of Mount Sinai.
Source: AJMCCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
In this @AJMC_Journal interview, Dr @EmmaGuttman discusses how #biologics and #JAKinhibitors have given patients with #AtopicDermatitus more treatment options. Watch now! https://t.co/GcUIOGe1a2 https://t.co/vO0l5IzLKE
-
-
Mashup Score: 1Quantitative and qualitative methods of evaluating response to biologics in severe asthma patients: Results from a real-world study - 1 year(s) ago
Asthma is a complex major noncommunicable disease affecting around 333 million people worldwide, both children and adults.1 New biological therapies for treating severe asthma have remarkably improved disease management. Notwithstanding, one remaining crucial problem is evaluating the response to these treatments. Therefore, adequate measurement of the response to biologics in a holistic manner…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Current Issue! #Quantitative and #qualitative methods of evaluating response to #biologics in severe #asthma #patients: Results from a real-world study https://t.co/wkc6pI4AGl https://t.co/IOYiwmRS5F
-
-
Mashup Score: 1Dual biologic therapy for the treatment of rheumatic diseases and asthma: a case series - 1 year(s) ago
AbstractObjective. Combination biological therapies are being considered increasingly for patients with multiple co-morbidities requiring biologics. There are l
Source: OUP AcademicCategories: Latest Headlines, RheumatologyTweet-
Combination #biological therapies are being considered increasingly for patients with multiple co-morbidities Data suggest combination #biologics can be used safely in #rheumatic disease #arthritis & #asthma 🤔Any other experiences? 👉🏽https://t.co/I1A8uSFCmb via @RheumJnl https://t.co/WDLBUArtsB
-
-
Mashup Score: 1
Patients reported improvements in social, personal satisfaction
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: Why was this an important review for patients with #psoriasis and their providers? #biologics #AADReadingRoom @AADskin #dermatology Read more: https://t.co/hl2odEsJMj https://t.co/xIjHSy6lJx
-
Dermatology Times’® Editorial Advisory Board member, Christopher Bunick, MD, PhD, of @yalederm, recently presented at the 2023 Fall Clinical Dermatology Conference to discuss how #biologics improve the lives of patients with #AtopicDermatitis. #FCPANP23 https://t.co/D5ZDRQ908Q